$6.62 +0.06 (0.92%) Sorrento Therapeutics Inc - NASDAQ

Aug. 26, 2016 | 04:00 PM
Last Trade: 6.62
Trade Time: Aug 26 04:00 PM Eastern Daylight Time
Change: +0.06 (0.92%)
Prev Close: 6.56
Open: 6.55
Bid: 6.61
Ask: 6.62
  1. No results found.
  1. Benzinga's Top Initiations

    Benzinga | Dec. 22, 2015 | 10:01AM EST
  2. Sorrento Therapeutics And City Of Hope Announce Exclusive License To Develop First-In-Class Immunotherapies Against Intracellular Targets

    Benzinga | Sep. 28, 2015 | 06:02AM EST
  3. Sorrento's TNK Therapeutics Subsidiary Acquires Multiple Clinical Stage CAR-T Immunotherapy Programs , no terms

    Benzinga | Aug. 10, 2015 | 06:00AM EST
  4. Sorrento Therapeutics In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies from Mabtech Limited

    Benzinga | Aug. 3, 2015 | 06:04AM EST
  5. Benzinga's Weekend M&A Chatter

    Benzinga | May. 17, 2015 | 20:41PM EST
  6. Benzinga's Volume Movers

    Benzinga | May. 15, 2015 | 10:49AM EST
  7. H.C. Wainwright's 8 Healthcare Stock Picks

    Benzinga | Jan. 13, 2015 | 07:08AM EST
  8. Conkwest Appoints Robert Rosen And Henry Ji To Its Board Of Directors

    Benzinga | Dec. 29, 2014 | 14:45PM EST
  9. Benzinga's Volume Movers

    Benzinga | Dec. 29, 2014 | 10:35AM EST
  10. US Stock Futures Up Ahead Of Earnings

    Benzinga | Dec. 19, 2014 | 07:48AM EST
  11. Morning Market Movers

    Benzinga | Dec. 15, 2014 | 09:44AM EST
  12. Sorrento Announces Strategic Investment By And Collaboration With Nantworks Founder Dr. Patrick Soon-Shiong For The Advancement Of Cancer Immunotherapies

    Benzinga | Dec. 15, 2014 | 09:25AM EST
  13. Events for the Week of Nov. 17-21, 2014

    Benzinga | Nov. 17, 2014 | 13:13PM EST
  14. UPDATE: MLV & Co. Initiates Coverage On Sorrento Therapeutics On Good Cynviloq Potential

    Benzinga | Jun. 19, 2014 | 07:57AM EST
  15. Stocks Hitting 52-Week Lows

    Benzinga | Dec. 19, 2013 | 10:33AM EST
Trading Center